WPP Health to host COVID-19 Q&A with LSHTM and WHO scientists

WPP Health Practice will host an exclusive live COVID-19 Q&A aimed at global media and policy makers, with experts from the London School of Hygiene & Tropical Medicine (LSHTM), today.

WPP Health is hosting a live Q&A for the media and policy makers with experts from LSHTM
WPP Health is hosting a live Q&A for the media and policy makers with experts from LSHTM

The online session, which begins at 1pm, is billed by WPP Health as a “rare opportunity to listen and interact with the scientists leading the world’s response to COVID-19”.

The session will be co-hosted by Jimmy Whitworth, professor of international public health at LSHTM and member of the Scientific Advisory Committee for the World Health Organization’s R&D Blueprint for Action to Prevent Epidemics, together with Heidi Larson, professor of anthropology, risk and decision science at LSHTM.

Whitworth previously led Medical Research Council programme initiatives on AIDS in Uganda and on onchocerciasis in Sierra Leone, while Larson is involved in the response to COVID-19 from a social science perspective – in particular, monitoring rumours and myths related to the outbreak.

Both scientists will be answering questions live on LSHTM’s Twitter and YouTube channels during the session – the second of its kind that WPP Health has hosted in the past fortnight.

LSHTM’s primary audiences are academics, scientists and policy makers around the world.

However, the live Q&A represents a drive by the institution to give a wider audience access to its experts, including the media and influencers in the health sector, as well as WPP staff and clients.

Katie Steels, head of comms and engagement at LSHTM, said: “Giving a global audience the opportunity to interact with such senior scientists in real time offers value to communities around the world – especially during an outbreak which is evolving so rapidly day by day.”

Steels said that during the Ebola outbreak in West Africa five years ago, LSHTM focused much of its time on helping health and science media tackle myths and misinformation, as well as leading calls for changes in how the epidemic was being tackled.

She added: “While we’re continuing with this strategy during this coronavirus outbreak, the live broadcasts have enabled us to extend our activity to offer direct access to our experts.”

Click here to subscribe to the FREE pharma and healthcare comms bulletin to receive dedicated healthcare news, features and comment straight to your inbox.

Make sure you register for the site to access more than one story per month.

To submit a news, comment, case study or analysis idea for the pharma and healthcare comms bulletin, email Ian.Griggs@haymarket.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in